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a b s t r a c t
Several studies have been performed to determine biomarkers that deﬁne the risk factors to developing
severe forms of dengue. In this study, the levels of TNF-α, IL-6, IL-1, IL-17, soluble interleukin-1 receptor
like 1 protein (sST2), soluble TNF-related apoptosis-inducing ligand (sTRAIL), IL-12 and soluble receptors
for TNF (sTNF-RI and sTNF-RII) were determined by ELISA in dengue patients and monocyte/macrophage
cultures. Dengue was classiﬁed as dengue without warning symptoms (DNWS), with warning symptoms
(DWWS) and severe dengue (SD). High values of IL-6, sTNFRI, sTNFRII and sST2 were observed in DWWS
and/or SD and IL-12 and sTRAIL in DNWS. TNF-α and IL-17 were increased not associated to the disease
severity. High production of TNF-α, IL-1β, IL-12, IL-17, sST2 and sTRAIL and apoptosis expression were
observed in dengue monocyte/macrophage cultures. This study shows that beneﬁcial or deleterious
biomarkers can be present in dengue regardless the disease severity and that monocytes may be in part
the source of studied molecules.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Dengue virus (DENV) is a single-stranded RNA virus that causes
disease in humans. DENV infection results in different clinical
manifestations ranking from benign disease (Halstead et al., 1970;
WHO, 2009). Due to the lack of efﬁcient biomarkers that deﬁne the
degree of severity, there is the need to ﬁnd relevant biological
markers of the disease. Several investigations have been focused in
DENV serotypes, type of infection and risk factors to developing
severe forms of the disease (Halstead et al., 1970; Monath, 1994;
Guzman et al., 1990). However, there are few studies relate to serum
levels of soluble biomarkers with possible beneﬁcial or deleterious
activities, during the course of dengue and theirs associationwith the
severity of disease, type of infection and DENV infection.
Several cytokines such as tumor necrosis factor alpha (TNF-α),
gamma interferon, interleukin (IL)-6, IL-1, IL-17, soluble interleukin-1
receptor like 1 protein (sST2) and soluble TNF-related apoptosis-
inducing ligand (sTRAIL) have been associated to deleterious effect
during dengue (Halstead et al., 1970; Gagnon et al., 2002; Espina
et al., 2003; Levy et al., 2010; Rachman and Rinaldi 2006; Huang
et al., 2003; Wu et al., 2013; Jain et al., 2013; Amatucci et al., 2007;
Tajima et al., 2007; Wajant et al., 2001), and IL-12 and soluble
receptors for TNF (TNF-RI and TNF-RII) with beneﬁcial effects (Pacsa
et al., 2000; Herbein and O’Brien, 2000; Vandenabeele et al., 1995).
Therefore, the aim of this study was to determine the serum levels
of TNF-α, IL-6, IL-1, IL-17, sST2, sTRAIL, IL-12, TNF-RI and TNF-RII in
patients infected by DENV and their association with the severity
of disease, type of infection (primary, secondary) and DENV type
infection. In addition, to determine the production of those biomar-
kers and the apoptosis expression by monocyte isolated from
dengue patients and healthy controls.
Results
Hematological and biochemical parameters of dengue patients
and healthy control are shown in Table 1. Decreased numbers of
platelets were observed in acute DNWS, DWWS and SD patients
compared to healthy controls. The lowest counts were observed in
SD patients. Prothrombin time (PT) and partial thromboplastin
time (PTT) were found to be increased in acute SD and PTT in acute
DWWS and SD. Counts of leukocytes were decreased in acute
DNWS, DWWS and SD. Liver enzymes were observed increased in
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dengue patients. Incremented AST values in acute DWWS and
acute and convalescence SD were observed. ALT was observed
increased in DNWS, DWWS (acute and convalescence) and SD
(acute and convalescence). Table 2 shows dengue patient distribu-
tion according to severity of disease, type of infection and dengue
type infection. Values of total studied serum molecules were found
to be increased, except IL-1β (Table 3). In general, biomarkers were
found to be increased in the different grades of dengue severity
(Fig. 1). High values of IL-6, sTNFRI, sTNFRII and sST2 were
observed in DWWS and/or SD and IL-12 and sTRAIL in DNWS.
TNF-α and IL-17 values were found to be increased compared to
healthy controls, but, no differences between the different grades
of the disease severity were observed. Values of studied com-
pounds were found to be increased in the acute period of disease,
reaching similar values to those observed in healthy controls in
the recovery period (Fig. 2). Dengue patients having secondary
infection showed increased values of sTNFRI, sTNFRII and sST2,
however, TNF-α, IL-6, IL-12, IL-17 and sTRAIL values remained
similar in primary and secondary infections (Fig. 3). All DENV
types were capable of inducing biomarker production in infected
patients. However, DENV-1 was associated to higher values of
IL-12 and sTRAIL; DENV-2 to sTNFRI, sTNFRII and sST2; DENV-3 to
IL-12 and DENV-4 to IL-6 and sST2 (Fig. 4).
Monocytes from dengue patients and healthy controls were
cultured for 5 days and biomarker contents were determined.
Increased contents of TNF-α, IL-1β, IL-12, IL-17, sST2 and sTRAILTa
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Table 2
Dengue patients according to severity of disease, type of infection and dengue type
infection.
Dengue
DNWS DWWS SD Total
n % n % n % n %
Infection:
Primary 5 42 3 30 0 0 8 27
Secondary 7 58 7 70 8 100 22 73
Viral typea
DENV-1 3 37.5 2 25 0 0 5 21
DENV-2 4 50 2 25 2 25 8 33
DENV-3 1 12.5 2 25 2 25 5 21
DENV-4 0 0 2 25 4 50 6 25
DNWS: dengue without warning symptoms; DWWS: dengue with warning
symptoms; SD: severe dengue.
a Viral isolation was obtained in 24 out of 30 dengue patients.
Table 3
Total serum cytokine and soluble receptor and ligand values in dengue and healthy
controls.
Cytokinea Healthy control (n¼10) Dengue (n¼30)
TNF-α 20.3873.24 47.36721.17b
IL-1β 5.1870.45 5.8070.87
IL-6 2.2171.03 6.1772.07b
IL-12 42.7279.85 86.25740.65b
IL-17 3.2772.19 45.93725.11b
sTNF-RI 15837458.30 335271720b
sTNF-RII 25477697.20 10,85875978b
sST2 22.0875.16 10,95079248b
sTRAIL 51.7178.02 95.81726.93b
a Cytokine values are expressed as pg/mL and media7standard deviation. TNF-
α: Tumor necrosis factor-alpha; IL-1β: Interleukin-1 beta; IL-6: Interleukin-6; IL-12:
Interleukin-12; IL-17: Interleukin-17; sTNF-RI: soluble tumor necrosis factor recep-
tor type I; sTNF-RII: soluble tumor necrosis factor receptor type II; sST2: Inter-
leukin-1 receptor like 1 protein; sTRAIL: soluble tumor necrosis factor -related
apoptosis inducing ligand
b po0.05 vs. healthy control.
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were observed in supernatants; however, IL-6 remained similar to
controls. (Fig. 5). sTNFRI and sTNFRII were not detected by ELISA.
High percentage of monocyte/macrophages from dengue patients
became apoptotic during the cultures (Fig. 6). Higher apoptotic
effect was observed at day 5 of culture and similar apoptotic effect
of DENV types was found (Fig. 7).
Fig. 1. Values of serum cytokines and soluble ligands and receptors for cytokines and apoptosis according to dengue severity. Dengue was classiﬁed as dengue
without warning symptoms (DNWS), dengue with warning symptoms (DWWS) and severe dengue (SD). TNF-α: tumor necrosis factor-alpha; IL-6, IL-12, IL-17: Interleukins-
6, 12, 17; sST2: soluble interleukin-1 receptor like 1 protein; sTRAIL: soluble TNF-related apoptosis-inducing ligand; TNF-RI and TNF-RII: soluble receptors for TNF type I
and II.
J. Arias et al. / Virology 452-453 (2014) 42–5144
Discussion
During this study several serum molecules were found to be
increased in patients with dengue suggesting a complex regulation
in the pathogenesis of this disease. Increased TNF-α found in
dengue patients were not modulated by the severity of disease,
type of infection or DENV type infection; however, TNF-α is believed
to play a signiﬁcant role in the pathogenesis of dengue, since
elevated levels of this cytokine in the sera have been reported in
infected patients (Gagnon et al., 2002; Espina et al., 2003; Levy et al.,
2010). TNF-α has been associated with apoptosis and hemorrhagic
manifestation in patients and in experimental dengue models
(Gagnon et al., 2002; Espina et al., 2003; Levy et al., 2010; Chen
et al., 2007); however, TNF-α could have beneﬁcial effect in dengue
since can inhibit DENV replication in monocyte-derived dendritic
cells (Shi et al., 2006). TNF-α has been associated to hemorrhagic
manifestations of dengue (Gagnon et al., 2002; Espina et al., 2003;
however, in this study, levels of TNF-α were not related to dengue
severity. This ﬁnding could be related to the expression of different
TNF polymorphism alleles (Chuansumrit et al., 2013; Alagarasu
et al., 2013; García-Trejo et al., 2011).
High levels of IL-6 were related to DWWS and DENV-4 infection in
this study, as previously observed in other groups of dengue patients
(Levy et al., 2010; Butthep et al., 2012; Priyadarshini et al., 2010). High
concentration of IL-6 has been implicated in the pathogenesis of
DWWS and SD. This cytokine enhances the production of anti-platelet
Fig. 2. Distribution of studied molecules according to phase evolution of dengue. Dengue was classiﬁed as dengue without warning symptoms (DNWS), dengue with
warning symptoms (DWWS) and severe dengue (SD). TNF-α: tumor necrosis factor-alpha; IL-6, IL-12, IL-17: Interleukins- 6, 12, 17; sST2: soluble interleukin-1 receptor like
1 protein; sTRAIL: soluble TNF-related apoptosis-inducing ligand; TNF-RI and TNF-RII: soluble receptors for TNF type I and II.
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or anti-endothelial cell auto antibodies and tissue plasminogen
activator, leading to plasma leakage and bleeding (Rachman and
Rinaldi, 2006; Huang et al., 2003). In addition, IL-6 increases dengue
virus replication in monocyte-derived dendritic cells (Shi et al., 2006).
As shown by other and in this study, high levels of IL-12 in
DNWS and decreased values in hemorrhagic forms of dengue were
observed, suggesting a protector role of IL-12 during severe illness,
since the absence of this cytokine may be responsible for the shift
to a Th2 type response and thus for the pathogenesis of dengue
hemorrhagic fever (Pacsa et al., 2000). In addition, IL-12/IL-18-
induces nitric oxide synthase 2 production, which is of major
importance to host resistance against DENV infection (0Fagundes
et al., 2011).
Increased expression of IL-17 found in this study was not
associated to severity of disease, type of infection or DENV type
infection. However, high IL-17 levels in children with severe
Fig. 3. Values of serum cytokines and soluble ligands and receptors for cytokines and apoptosis according to the type infection. TNF-α: tumor necrosis factor-alpha; IL-6,
IL-12, IL-17: Interleukins- 6, 12, 17; sST2: soluble interleukin-1 receptor like 1 protein; sTRAIL: soluble TNF-related apoptosis-inducing ligand; TNF-RI and TNF-RII: soluble
receptors for TNF type I and II.
J. Arias et al. / Virology 452-453 (2014) 42–5146
Fig. 4. Values of serum cytokines and soluble ligands and receptors for cytokines and apoptosis according to dengue virus infection. TNF-α: tumor necrosis factor-alpha;
IL-6, IL-12, IL-17: Interleukins- 6, 12, 17; sST2: soluble interleukin-1 receptor like 1 protein; sTRAIL: soluble TNF-related apoptosis-inducing ligand; TNF-RI and TNF-RII:
soluble receptors for TNF type I and II.
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dengue, secondary infection and DENV-2 infection have been
reported, suggesting a role for IL-17 in severe dengue (Jain et al.,
2013). The exact role of IL-17 in the pathogenesis of severe DENV
infection remains to be elucidated.
Levels of IL-1β in dengue were similar to those observed in
healthy control. This observation has been previously reported
in vitro and in dengue patients by others (Levy et al., 2010;
Butthep et al., 2012; Soemanto et al., 1999). These ﬁndings suggest
that IL-1 β probably does not play an important role in the
pathogenesis of this disease. However, this could be controversial,
since, in this study, IL-1β was observed increased in monocyte/
macrophage cultures from dengue patients.
The effects of TNF-α are mediated by two speciﬁc receptors,
TNF-RI and TNF-RII, which are bound to the cell surface, but by
proteolytic cleavage can be released to the environment (Herbein
and O’Brien, 2000; Vandenabeele et al., 1995). In this study
increased levels of sTNF-RI and RII associated to DWWS, SD and
DENV-2 and DENV-4 infections were observed. Our data are
consistent with previous report where increased expression of
TNF-RII was associated to hemorrhagic manifestation of dengue
(Bethell et al., 1998); however, the presence of these receptors in
dengue could be controversial, since serum TNF-RI and RII were
found elevated in dengue not associated to the severity of disease
(Braga et al., 2001; Pinto et al., 1999; Hober et al., 1996).
Theoretically, sTNFR I and RII can diminish the activity of TNF-α,
but they may also increase its function by stabilizing the active
TNF-α oligomer (Herbein and O’Brien, 2000; Vandenabeele et al.,
1995). The balance between sTNFRs and TNF-α may be important
in deﬁne the course of dengue infection.
Fig. 5. Cytokines and soluble ligands and receptors for cytokines and apoptosis
production by monocyte cultures from dengue patients and healthy controls. TNF-
α: tumor necrosis factor-alpha; IL-6, IL-1, IL-12, IL-17: Interleukins- 6, 1, 12, 17; sST2:
soluble interleukin-1 receptor like 1 protein; sTRAIL: soluble TNF-related apopto-
sis-inducing ligand.
Fig. 6. Apoptosis expression in day 5 of monocyte/macrophage cultures from dengue patients and healthy controls. (A) Percentage of TUNEL positive cells in cultures.
(B) TUNEL immunoﬂuorescence staining from healthy control cultures. (C) TUNEL immunoﬂuorescence staining from dengue monocyte/macrophage cultures. Arrows
show apoptotic positive cells.
Fig. 7. Apoptosis induction by the different dengue virus types in monocyte/
macrophage cultures. Increased expression of apoptosis in days 3 and 5 of culture,
regardless virus type was observed.
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Soluble ST2 has been recently reported to be elevated in the
serum of patients with DENV infection and it was correlated
with secondary infections and with severe forms of the disease
(Guerrero et al., 2013; Houghton-Trivino et al., 2010; Becerra et al.,
2008). In this study sST2 levels were observed increased in SD,
secondary infection and in DENV-2 and DENV4 infections.
sST2 function during DENV infection remains unknown. Previous
reports have suggested that sST2 could be involved in the
inﬂammatory and Th2 immune responses (Amatucci et al., 2007;
Tajima et al., 2007). However, sST2 could act as an anti-
inﬂammatory mediator, by inhibition of Toll-like receptor signal-
ing (Sweet et al., 2001; Brint et al., 2004) or inhibition of I-κB
degradation (Takezako et al., 2006). Therefore, elevated sST2 levels
found in dengue patients may be an indication of the immune
hyperactivation and/or down-regulation of inﬂammation. High
levels of cytokines such as TNF-α and IL-6 found in this study
could induce sST2 (Kumar et al., 1997; Tajima et al., 2003).
TRAIL is expressed on the cell membrane and signals apoptosis
via the death domain-containing receptors TRAIL-R1 and TRAIL-
R2. In this study, high values of sTRAIL were observed in DNWS
patients and DENV-1 infection. DNWS is a benign form of dengue
and the apoptotic effect of sTRAIL could diminish the viral
replication (Everett and McFadden, 1999) during the disease. In
addition, high levels of sTRAIL were associated to high production
of interferon-α, a cytokine with antiviral effect (Gandini et al.,
2013). These data support the role of sTRAIL inducing mild form of
dengue mediate by apoptosis and antiviral cytokines. Our results
showed that monocytes/macrophage isolated from dengue
patients were capable of producing elevated concentration of
sTRAIL in culture supernatants, suggesting a role of these cells in
the increased serum concentration of sTRAIL found in dengue
patients and a role of sTRAIL in the increased apoptosis found in
those cultures. It was not determined viral presence in monocytes
cultures, but, since in vitro infection of human primary monocytes,
B cells and dendritic cells with DENV induces high levels of sTRAIL
(Gandini et al., 2013; Becerra et al., 2009), we cannot rule out a
role of cell-virus infection in sTRAIL production.
The source of cytokines, soluble receptors and ligands found
increased in dengue patients could come from several cell types
(Gagnon et al., 2002; Chen et al., 2007; Shi et al., 2006). Monocytes
from dengue patients produced several cytokines found in
patient0s serum (TNF-α, IL-12, IL-17, sST2 and sTRAIL); however,
failed to produced others (sTNFRI and sTNFRII), suggesting a
partial role of monocytes in the serum content of those molecules.
Apoptosis is a regulatory feature of the immune system. In
response to viral infection, apoptosis may occur as a pathogen-
directed mechanism of viral dissemination and immune escape or
may represent an appropriate host response for limiting virus
replication (Everett and McFadden, 1999; Myint et al., 2006).
Apoptosis seems to be a relevant mechanism in cell damage
during dengue (Espina et al., 2003; Levy et al., 2010; Myint et al.,
2006; Mosquera et al., 2005; Morchang et al., 2011). In this study,
cultured monocytes from patients with dengue showed high
expression of apoptosis. In this regard, it has been reported that
DENV is capable of inducing apoptosis in experimental infection of
monocyte line (Klomporn et al., 2011), suggesting that by intrinsic
way, dengue virus can induce apoptosis (Myint et al., 2006;
Morchang et al., 2013; Netsawang et al., 2010). In addition,
cytokines induced by dengue infection in monocytes and other
cell types can lead to apoptosis (Espina et al., 2003; Levy et al.,
2010; Morchang et al., 2011; Leong et al., 2007). In this study,
monocytes from dengue patients produced high levels of TNF-α,
and sTRAIL and were not capable of producing sTNFRs; these
conditions can induce apoptosis. In this regard, high levels of TNF-
α in dengue patients has found to be associated to apoptosis
(Espina et al., 2003; Levy et al., 2010; Klomporn et al., 2011; Jaiyen
et al., 2009). The presence of this cytokine in monocyte/macro-
phage cultures could lead to apoptosis and the action of TNF could
be enhanced, since sTNFRs were absent. In addition, the action of
sTRAIL on cell membrane TNF receptors can contribute to higher
expression of apoptosis (Wajant et al., (2001).
In conclusion, the response to dengue virus infection in this
study was characterized by the production of several cytokines,
soluble ligands and receptors, and the overall picture appears to be
complex. The presence of beneﬁcial or deleterious biomarkers is
not related to disease severity, type of infection or DENV infection;
therefore, specify proﬁles for dengue were not observed. The
balance between protective and pathologic molecules instead of
only their presence, could lead to deﬁne the course of dengue.
Apoptosis seems to be an important mechanism of cell damage in
dengue as reﬂected by the high percentage of monocytes triggered
for apoptosis. This study deﬁnes the presence of beneﬁcial and
deleterious molecules during dengue infection, however, the
precise role and interactions of those molecules remain to be
studied in association with clinical outcomes.
Materials and methods
Patients
Thirty male and female patients (1–39 years old) presenting
clinical diagnosis of dengue according to WHO criteria (WHO,
2009) were studied. Dengue patients were classiﬁed as dengue
without warning symptoms (DNWS), dengue with warning symp-
toms (DWWS) and severe dengue (SD). In addition to suggestive
clinical diagnosis, dengue virus infection was conﬁrmed either by
the presence of serum anti- dengue antibodies or by virus
isolation. Blood samples were taken during the acute phase (1–6
days after the onset of the symptoms), during the convalescent
phase (7–26 days after the onset of the symptoms) and during the
recovery phase. Dengue immune response was considered as
primary or secondary by serum immunoglobulin pattern as
determined by ELISA (Diagnostic Automation, Inc., Calabasas,
USA). In addition, the acute-phase samples were subjected to
virus isolation through cell culturing with the C6/36 mosquito cell
line obtained from Aedes albopictus( Tesh, 1979). Virus serotypes
were determined by indirect immunoﬂuorescence using mono-
clonal antibodies. Patients with cardiovascular, hematological,
hepatic, lung, kidney and autoimmune diseases, hypertension,
diabetes, cancer, pregnancy, treated with steroids or immunesup-
presors and infections with bacteria or other virus were exclude
from this study. The blood samples obtained from similar age and
sex healthy individuals (n¼10; age: 2–42 years old) were used as
controls. Samples from patients and controls were stored at
70 1C until used and tested for studied molecules and biochem-
ical parameters. The Ethics Committee of Instituto de Investiga-
ciones Clínicas Dr. Américo Negrette and FONACIT (Caracas,
Venezuela) approved this study protocol and written informed
consent was obtained from all patients or parents prior blood
collection in accordance with the ethical standards of Declaration
of Helsinki (1964).
Laboratory studies
IL-1β, IL-6, TNFα and IL-12 contents were measured using a
commercially available ELISA kits (Thermo Scientiﬁc, MA, USA) as
well as IL-17, sTRAIL, sST2, sTNF-RI and sTNF-RII (R&D Systems,
Inc., MN, USA). The results are expressed as pg/ml or pg/mg of
cellular protein.
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Monocyte/macrophage cultures
Mononuclear leukocytes were obtained from heparinised
venous blood from 8 seronegative healthy adult donors and
8 dengue patients during the acute phase by density gradient
centrifugation in Hystopaque 1.077 (Sigma Chemical Co. St. Louis
MO, USA). Cells were cultured in supplemented RPMI 1640 and
incubated at 37 1C and 5% CO2. After 3 hour-incubation, adherent
cells were enriched by washing away unattached cells. After 5 days
supernatants were collected and biomarker contents were deter-
mined as described. Cells were sonicated for protein determina-
tion. Culture purity was assessed by an FITC-conjugated anti-
human CD14 monoclonal antibody (Sigma Chemical Co., St. Louis,
MO, USA) and by a microscopy with epiﬂuorescence system
(Zeiss, Germany). Apoptosis was determined in attached cells after
3 and 5 days of culture by the TUNEL assay.
TUNEL assay
Cultured monocyte/macrophages from studied groups were
ﬁxed with 1% paraformaldehyde in PBS and permeabilized with
acetic acid: ethanol. The percentages of apoptotic cells were
assessed by TUNEL reaction using the In situ Apop Tag kit (Chemi-
con International; USA and Canada) according to the manufacturer0s
instructions.
Statistical analysis
Values were expressed as mean7SD. The signiﬁcance of
differences was tested by ANOVA and the Bonferroni post hoc
test. Two tailed po0.05 values were considered statistically
signiﬁcant.
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